Endo names former Sandoz President as COO

Endo names former Sandoz President as COO

Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that it has appointed Don DeGolyer as Chief Operating Officer, Pharmaceuticals, which includes Endo Pharmaceuticals and Qualitest, effective August 1, 2013.

“Don is a uniquely qualified, seasoned leader with nearly three decades of experience in the healthcare industry. Don has broad experience in both branded and generic pharmaceuticals and I have tremendous confidence in his ability to drive operational excellence and growth,” said Rajiv De Silva, President and Chief Executive Officer of Endo Health Solutions.

“I am extremely excited to join Rajiv and the other members of the Endo team as the company enters a new phase of growth and expansion,” said Don DeGolyer. “I believe that Endo is in an excellent position to deliver value to customers, employees and shareholders over the near term and I look forward to being a part of this exciting transformation.”

Most recently, Mr. DeGolyer served as President and CEO of Sandoz Inc., Novartis’ North America generic pharmaceuticals unit. Prior to joining Novartis in 2002, he spent 11 years at Johnson & Johnson in various roles of increasing responsibility, including Vice President of Marketing and Sales, and began his career at Pfizer, Inc.

Read the source article at online.wsj.com

About the Author

Leave a Reply

*